Nilai Total Perusahaan: Evolus, Inc. (EOLS)

Evolus, Inc. (EOLS) is expanding its aesthetic medicine business, focusing on European expansion and attracting younger clients through Jeuveau. However, intense competition and pressure from low-cost Asian alternatives are forcing the company to fight for clinic loyalty. Simultaneously, the company is implementing software for patient tracking and predictive analytics. This market valuation chart confirms these trends, with the current figure standing at 606.42.

EOLS Rega Nyata Tumbas Perusahaan Kanthi Wutuh evolus.com (23.11.2025 - 28.10.2026)

Rincian metrik keuangan lan pasar Evolus, Inc. (EOLS)

- rega lan prakiraan konsensus rega:

Rega bursa Evolus Inc|EOLS - Bagan rega target

- data kapitalisasi pasar:

Nilai pasar Evolus|EOLS - Nilai Total Perusahaan

- data kapitalisasi buku:

Aset Bersih saben Saham Evolus|EOLS - Aset Bersih Perusahaan|Multiplikator Kapitalisasi Pasar marang Nilai Buku evolus.com|EOLS - Aset Agregat Perusahaan

- data utang lan likuiditas:

Rasio Kabeh Utang marang Dana Pribadi Evolus, Inc.|EOLS - Utang jangka dawa marang modal|Kewajiban jangka cendhak marang modal evolus.com|EOLS - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku Evolus|EOLS - Kewajiban jangka dawa perusahaan|Gedhene kewajiban jangka cendhak Evolus

Ringkesan analitik perusahaan:EOLS - Evolus Inc

When screening assets, an investor uses this metric to determine the actual cost of acquiring a business by summing the market capitalization and net debt. The calculation logic of Enterprise Value (EV) allows for an assessment of the financial stability of Evolus, Inc. (EOLS) amid price wars with Asian competitors in the aesthetic medicine segment, revealing the real price of the asset inclusive of all credit obligations.

Pesaing Evolus, Inc.